VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
11.04 CAD
+0.03 (+0.27%)
Overall VHI gets a fundamental rating of 6 out of 10. We evaluated VHI against 9 industry peers in the Health Care Technology industry. While VHI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
VHI's Return On Assets of 1.79% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Return On Equity of 2.71%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Return On Invested Capital of 3.20%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 3.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROIC | 3.2% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI's Profit Margin of 5.99% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin of 12.27% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 80.89%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
Compared to 5 years ago, VHI has more shares outstanding
Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.04 indicates that VHI is not in any danger for bankruptcy at the moment.
The Altman-Z score of VHI (5.04) is better than 66.67% of its industry peers.
The Debt to FCF ratio of VHI is 1.16, which is an excellent value as it means it would take VHI, only 1.16 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.16, VHI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
VHI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.08, VHI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 5.04 |
ROIC/WACC0.36
WACC8.89%
2.3 Liquidity
VHI has a Current Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VHI (1.59) is better than 77.78% of its industry peers.
A Quick Ratio of 1.59 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a better Quick ratio (1.59) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.00% over the past year.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.68%.
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
3.2 Future
The Earnings Per Share is expected to grow by 78.25% on average over the next years. This is a very strong growth
Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 25.88% on average per year.
EPS Next Y92.98%
EPS Next 2Y106.31%
EPS Next 3Y78.25%
EPS Next 5YN/A
Revenue Next Year53.4%
Revenue Next 2Y35.87%
Revenue Next 3Y25.88%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 110.40, the valuation of VHI can be described as expensive.
Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, VHI is valued quite expensively.
The Price/Forward Earnings ratio is 37.05, which means the current valuation is very expensive for VHI.
Based on the Price/Forward Earnings ratio, VHI is valued cheaper than 88.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (22.71), we can say VHI is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.4 | ||
| Fwd PE | 37.05 |
4.2 Price Multiples
VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.5 | ||
| EV/EBITDA | 34.26 |
4.3 Compensation for Growth
VHI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 78.25% in the coming years.
PEG (NY)1.19
PEG (5Y)N/A
EPS Next 2Y106.31%
EPS Next 3Y78.25%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (9/16/2025, 7:00:00 PM)
11.04
+0.03 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.31%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap692.32M
Analysts81.54
Price Target15.84 (43.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.3%
Min EPS beat(2)-54.3%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-35.59%
Min EPS beat(4)-54.3%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.95%
EPS beat(12)1
Avg EPS beat(12)-44.36%
EPS beat(16)2
Avg EPS beat(16)-71.47%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)0.61%
Max Revenue beat(2)7.24%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)7.24%
Revenue beat(8)6
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)2.84%
Revenue beat(16)12
Avg Revenue beat(16)3.4%
PT rev (1m)5.67%
PT rev (3m)12.93%
EPS NQ rev (1m)-28.01%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-38.81%
EPS NY rev (3m)-38.81%
Revenue NQ rev (1m)4%
Revenue NQ rev (3m)32.02%
Revenue NY rev (1m)4.56%
Revenue NY rev (3m)17.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.4 | ||
| Fwd PE | 37.05 | ||
| P/S | 8.38 | ||
| P/FCF | 51.5 | ||
| P/OCF | 48.67 | ||
| P/B | 3.8 | ||
| P/tB | 22.26 | ||
| EV/EBITDA | 34.26 |
EPS(TTM)0.1
EY0.91%
EPS(NY)0.3
Fwd EY2.7%
FCF(TTM)0.21
FCFY1.94%
OCF(TTM)0.23
OCFY2.05%
SpS1.32
BVpS2.91
TBVpS0.5
PEG (NY)1.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROCE | 5.04% | ||
| ROIC | 3.2% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% | ||
| FCFM | 16.27% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.87 | ||
| Cap/Depr | 10.65% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.38% | ||
| Profit Quality | 271.64% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 5.04 |
F-Score3
WACC8.89%
ROIC/WACC0.36
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y92.98%
EPS Next 2Y106.31%
EPS Next 3Y78.25%
EPS Next 5YN/A
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
Revenue Next Year53.4%
Revenue Next 2Y35.87%
Revenue Next 3Y25.88%
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year62.54%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y81.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.62%
OCF growth 3YN/A
OCF growth 5YN/A